CEO Richard Pops said the company is entering what he described as a “really exciting year” as the orexin agonist field moves closer to commercialization in narcolepsy, with broader ambitions in other ...

Chief Executive Officer Mario Alberto Accardi told investors at the Leerink Partners Global Healthcare Conference that the company is aiming to establish its orexin-2 agonist program as a “best-in-cla ...

That lucky friend of yours — the one who barely gains weight when eating the same things you eat, even though your waistline expands — might have a hormone called orexin to thank. A new study shows ...

CHICAGO -- Novel orexin receptor 2 agonist oveporexton normalized wakefulness for most people with narcolepsy type 1 in two randomized phase III trials. Mean sleep latency across four, 40-minute ...

Researchers reveal orexin's crucial role in deciding between physical activity and high-reward foods. Key to tackling obesity and sedentary behavior. Orexin is essential in choosing between exercise ...

Researchers at the University of Pennsylvania School of Medicine have discovered that the recently identified neurotransmitter orexin (also known as hypocretin) influences reward processing by ...

The neurotransmitter orexin regulates motivated behaviors such as arousal and feeding—and is now implicated in behaviors associated with addiction in rats. The release of orexin onto dopamine cells ...

For advanced activities of our daily life (such as driving a car, or seeing a movie), to be awake is important. It has been known so far that neuropeptide in the brain called "Orexin" controls sleep ...

The way the brain regulates pupil size is different from previously thought: fundamentally responsible is the neurotransmitter orexin, as researchers at ETH Zurich have now shown. This discovery could ...

STANS, Switzerland, May 18, 2021 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and ...

Hedonic hotspots are brain sites where particular neurochemical stimulations causally amplify the hedonic impact of sensory rewards, such as “liking” for sweetness. Here, we report the mapping of two ...